These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18035065)

  • 1. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.
    Gouazé-Andersson V; Yu JY; Kreitenberg AJ; Bielawska A; Giuliano AE; Cabot MC
    Biochim Biophys Acta; 2007 Dec; 1771(12):1407-17. PubMed ID: 18035065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity.
    Chapman JV; Gouazé-Andersson V; Cabot MC
    Int J Oncol; 2010 Dec; 37(6):1591-7. PubMed ID: 21042729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein.
    Goulding CW; Giuliano AE; Cabot MC
    Cancer Lett; 2000 Feb; 149(1-2):143-51. PubMed ID: 10737718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
    Chapman JV; Gouazé-Andersson V; Karimi R; Messner MC; Cabot MC
    Exp Cell Res; 2011 Jul; 317(12):1736-45. PubMed ID: 21396934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.
    Gouazé V; Yu JY; Bleicher RJ; Han TY; Liu YY; Wang H; Gottesman MM; Bitterman A; Giuliano AE; Cabot MC
    Mol Cancer Ther; 2004 May; 3(5):633-9. PubMed ID: 15141021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
    Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G
    Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
    Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
    Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.
    Zhang X; Wu X; Li J; Sun Y; Gao P; Zhang C; Zhang H; Zhou G
    J Surg Oncol; 2011 Oct; 104(5):466-71. PubMed ID: 21538359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
    Turzanski J; Grundy M; Shang S; Russell N; Pallis M
    Exp Hematol; 2005 Jan; 33(1):62-72. PubMed ID: 15661399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
    Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
    Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
    Shabbits JA; Mayer LD
    Mol Cancer Ther; 2002 Jan; 1(3):205-13. PubMed ID: 12467215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.
    Zhao L; Jin X; Xu Y; Guo Y; Liang R; Guo Z; Chen T; Sun Y; Ding X
    J Exp Clin Cancer Res; 2010 Jul; 29(1):98. PubMed ID: 20642825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
    Norris-Cervetto E; Callaghan R; Platt FM; Dwek RA; Butters TD
    J Biol Chem; 2004 Sep; 279(39):40412-8. PubMed ID: 15263008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
    J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein.
    Zhang Q; Wang J; He H; Liu H; Yan X; Zou K
    Phytother Res; 2014 Jul; 28(7):1037-44. PubMed ID: 25289403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells.
    Wegner MS; Schömel N; Gruber L; Örtel SB; Kjellberg MA; Mattjus P; Kurz J; Trautmann S; Peng B; Wegner M; Kaulich M; Ahrends R; Geisslinger G; Grösch S
    Cell Mol Life Sci; 2018 Sep; 75(18):3393-3410. PubMed ID: 29549423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.